Cart
sales@molnova.com
h-NTPDase-IN-2
CAS No. 2939933-03-4
h-NTPDase-IN-2( —— )
Catalog No. M37244 CAS No. 2939933-03-4
h-NTPDase-IN-2 is a broad-spectrum NTPDase inhibitor that inhibits multiple h-NTPDas isoforms.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 728 | Get Quote |
|
| 5MG | 1026 | Get Quote |
|
| 10MG | 1359 | Get Quote |
|
| 25MG | 1702 | Get Quote |
|
| 50MG | 2006 | Get Quote |
|
| 100MG | 2502 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Nameh-NTPDase-IN-2
-
NoteResearch use only, not for human use.
-
Brief Descriptionh-NTPDase-IN-2 is a broad-spectrum NTPDase inhibitor that inhibits multiple h-NTPDas isoforms.
-
Descriptionh-NTPDase-IN-2 (compound 3l) is a pan-inhibitor of h-NTPDase, with IC50s of 0.35 μM (h-NTPDase1), 4.81 μM (h-NTPDase2), 37.73 μM (h-NTPDase3), 10.32 μM (h-NTPDase8), respectively.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorPhosphatase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2939933-03-4
-
Formula Weight332.42
-
Molecular FormulaC19H16N4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN=1C=CC(=CC1)C2=CSC3=C2N=CN=C3N(C)CC=4C=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zaman G, et al. Synthesis of Thieno [3, 2‐d] pyrimidine Derivatives through Sequential SNAr and Suzuki Reactions as Selective h‐NTPDases Inhibitors[J]. ChemMedChem, 2023: e202300165. .
molnova catalog
related products
-
AS1949490
AS1949490 activated glucose metabolism via up-regulation of GLUT1 gene in L6 myotubes.
-
LMPTP INHIBITOR 1 hy...
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
-
Calcineurin Autoinhi...
Selective inhibitor of Ca2+-calmodulin-dependent protein phosphatase (calcineurin) (IC50 ~ 10 μM). Does not inhibit PP1, PP2A or CaM kinase II (IC50 > 100 mM).
